The Motley Fool

TFSA Investors: 3 TSX Stocks I’d Buy for 2020

Image source: Getty Images

It’s that time again at year end, when investors have to think about rebalancing their portfolios, chucking out underperformers, and adding some growth candidates and stable dividend income generation stocks to create long-term, outperforming TFSA retirement portfolios.

Growing a retirement nest egg shouldn’t be too much of a hustle, as the TSX offers some of the most compelling stable growth stocks that can make up core portfolio holdings, and one may choose to get a little greedier and power up the tax-free investment account with lottery-ticket-like positions that could appreciate significantly in a short term.

There are three good candidates for 2020 that I am looking at, and I will start off with the most cash flow stable option, and it’s a real estate investment trust (REIT).

Northwest Healthcare Properties

Canadian REITs have largely taken off this year, and income yields have come down, but Northwest Healthcare Properties Real Estate Investment Trust (TSX:NWH.UN) units pay a monthly distribution that still offers a juicy 6.5% yield today.

The trust holds a big portfolio of 169 healthcare properties located in Canada, Brazil, Australia, New Zealand, and Europe with a strong occupancy rate and a 14-year average lease term that help secure the healthy monthly distribution.

The REIT managed to upsize its Australian joint venture by $1.6 billion recently, and this could result in operating economies of scale while management has been refinancing some of its expensive loans at lower rates this year to free up more cash flow for growth projects. Units could appreciate in price over the next few years, as new development projects start contributing to funds flow.

Bridging the dividend-growth gap

Enbridge (TSX:ENB)(NYSE:ENB) stock is my next consideration.

REIT distributions may be stable, but they may not grow as fast as those from this utilities and energy infrastructure giant. Enbridge’s solid dividend-growth history and a strong free cash flow growth outlook makes the stock a compelling income play in a retirement-focused core portfolio.

Its regulated and contracted rates provide high cash flow visibility, even during times of low commodity prices, while its recently increased capital-expenditure budget could grow distributable cash flows over the next five years. Dividends will continue growing, and the annual yield on cost could keep become juicier than the current 5.9% in the long term.

Most importantly, shares have traded sideways for over three years, good entry points still exist before the rally.

Lastly, a cannabis lottery ticket

Aphria (TSX:APHA)(NYSE:APHA) is a cannabis stock with significant sales growth potential after receiving a long-awaited, critical production licence recently, but earlier scandals significantly lowered its valuation multiples as compared to peers.

Shares were beaten down along with the peer group, as market growth fears gripped the investing community in response to a plethora of bad news, scary earnings guidance revocations, and expansion projects suspensions by some competitors, but more retail store roll-outs from 2020 could bring better winning prospects for the nascent marijuana industry against a stubborn underground cannabis market.

The company has a robust distribution network through a Germany subsidiary that only requires European Union Good Manufacturing Practices certifications for its Canadian production facilities to tap into a fast-growing high-margin market. The certification process is already underway, while a Germany production tender win could further propel revenue growth.

Unlike most peers (excluding Cronos Group and Canopy Growth), the company remains one of the most well-funded pot firms for its size, and its business processes have proved to be profitable, even before volume growth and stabilized operating costs could provide significant operating leverage in the next year.

APHA stock could significantly outperform the TSX over the next two to three years.

Just Released! 5 Stocks Under $49 (FREE REPORT)

Motley Fool Canada's market-beating team has just released a brand-new FREE report revealing 5 "dirt cheap" stocks that you can buy today for under $49 a share.
Our team thinks these 5 stocks are critically undervalued, but more importantly, could potentially make Canadian investors who act quickly a fortune.
Don't miss out! Simply click the link below to grab your free copy and discover all 5 of these stocks now.

Claim your FREE 5-stock report now!

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Enbridge. The Motley Fool recommends NORTHWEST HEALTHCARE PPTYS REIT UNITS.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss an important event.

Iain Butler and the Stock Advisor Canada team only publish their new “buy alerts” twice a month, and only to an exclusively small group.

This is your chance to get in early on what could prove to be very special investment advice.

Enter your email address below to get started now, and join the other thousands of Canadians who have already signed up for their chance to get the market-beating advice from Stock Advisor Canada.